Molecular aspects of insulin therapy in critically ill patients

Area of Science:

• Critical care medicine
• Molecular endocrinology
• Biochemistry

Background:

• Critically ill patients face high mortality risks, often exacerbated by insulin resistance.
• Intensive insulin therapy has shown promise in reducing morbidity in this population.
• The precise molecular mechanisms underlying insulin's beneficial effects in insulin-resistant critically ill patients require further elucidation.

Purpose of the Study:

• To review the molecular mechanisms behind the beneficial effects of insulin in insulin-resistant critically ill patients.
• To explore how insulin impacts inflammation, oxidative stress, and mitochondrial function in this context.

Main Methods:

• This study is a review of existing literature on insulin's molecular actions.
• It synthesizes findings on insulin's effects on inflammation, reactive oxygen species, mitochondrial function, and microcirculation.

Main Results:

• Intense insulin therapy reduces morbidity in critically ill patients.
• Insulin mitigates inflammation and oxidative stress via pathways involving free fatty acids and hyperglycemia.
• Insulin preserves mitochondrial function, enhances adiponectin secretion, modulates AMP-activated protein kinase, and improves microcirculation by reducing inducible nitric oxide synthase.

Conclusions:

• Tight glucose control with intense insulin therapy improves outcomes for critically ill patients.
• Understanding insulin's metabolic and non-metabolic molecular pathways offers insights into multiple organ failure pathogenesis.
• Further research into these mechanisms can guide novel therapeutic strategies for intensive care patients.